Nexalin Technology (NXL) Receivables (2021 - 2026)
Nexalin Technology's (NXL) quarterly Receivables came in at $43004.0 in Q1 2026, down 58.57% year-on-year from $103809.0 in Q1 2025, and down 47.28% quarter-over-quarter from $81571.0 in Q4 2025.
Nexalin Technology (NXL) Receivables (2021 - 2026) Analysis & Trends
Nexalin Technology's Receivables history runs 6 years deep, the most recent figure standing at $43004.0 for Q1 2026.
- On a quarterly basis, Receivables fell 58.57% year-over-year to $43004.0 in Q1 2026; TTM through Mar 2026 was $43004.0, a 58.57% decrease from a year earlier, with the FY2025 full-year figure at $81571.0, down 20.32% from the prior year.
- Receivables fell to $43004.0 in Q1 2026 per NXL's latest filing, from $81571.0 in the prior quarter.
- Across five years, Receivables topped out at $350483.0 in Q3 2023 and bottomed at $35025.0 in Q3 2025.
- The 5-year median for Receivables is $103809.0 (2025), against an average of $172985.4.
- Across the five-year window, Receivables tumbled 72.61% in 2024 and increased 11.63% in 2025, its largest moves.
- Year by year, Receivables stood at $340875.0 in 2022, then plunged by 71.05% to $98699.0 in 2023, then grew by 3.72% to $102373.0 in 2024, then retreated by 20.32% to $81571.0 in 2025, then sank by 47.28% to $43004.0 in 2026.
- Per Business Quant, the three latest NXL Receivables figures stand at $43004.0 (Q1 2026), $81571.0 (Q4 2025), and $35025.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 43,004.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,004.00 |
| Dec 31, 2025 | 81,571.00 |
| Sep 30, 2025 | 35,025.00 |
| Jun 30, 2025 | 104,171.00 |
| Mar 31, 2025 | 103,809.00 |
| Dec 31, 2024 | 102,373.00 |
| Sep 30, 2024 | 104,501.00 |
| Jun 30, 2024 | 101,050.00 |
| Mar 31, 2024 | 92,996.00 |
| Dec 31, 2023 | 98,699.00 |
| Sep 30, 2023 | 350,483.00 |
| Jun 30, 2023 | 350,322.00 |
| Mar 31, 2023 | 339,550.00 |
| Dec 31, 2022 | 340,875.00 |
| Sep 30, 2022 | 346,352.00 |
| Dec 31, 2021 | 352,303.00 |